Skip to main content
. 2019 Feb 26;11:1179299X19830977. doi: 10.1177/1179299X19830977

Table 1.

Stage I ovarian cancer tumour biomarker sensitivity in patient serum.

Biomarker(s) Sensitivity at 95% specificity (%) Sensitivity at 98% specificity (%)
HE4 45.9 30.8
CA125 + HE4 39.5 38.4
CA125 + osteopontin 15.3 15.3
CA125 15.1 7.7
Osteopontin 14.7 7.6

Adapted from Moore et al43.